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background: Previous trials comparing carotid artery stenting (CAS) with carotid endarterectomy (CEA) demonstrated controversial 
results, mainly in symptomatic patients, because of higher stroke rate. However, the increase of the experience of the operators, the 
improvement of the stents and of the embolic protection devices (EPDs) has made CAS a highly competitive procedure. In this study we 
tried to assess the feasibility and the safety of using double EPD (proximal and distal) in high-risk patients.
methods: We collected data about all consecutive patients with symptomatic or asymptomatic carotid artery stenosis who underwent 
CAS and analyzed clinical and procedural characteristics as well as immediate and 30-day outcomes. All the procedures were performed 
after a jointed discussion of the case with neurologist. Neurologic visits and duplex scans were scheduled 24 hours and 1 month after the 
procedure.
results: Between November 2007 and 31st August 2014, 294 underwent CAS. In 35 of them (11.9%) double EPD was used (distal filter 
+ MoMa, Medtronic, Minneapolis, MN). The whole population was at high cardiovascular risk: 50.7% of the patients had known coronary 
artery disease, 5.8% congestive heart failure, 41.5 % aged ≥75 years. Many patients (38.9.%) had a complex plaque (soft, ulcerated, with 
thrombus). The stent implanted were closed-cell in 64.6%, hybrid in 23.8% and open cell in 12.2%. In comparison with the patients treated 
with single EPD, those with double EPD presented an higher rate of complex plaque (79.4% vs 33.6%, p<0.0001). There was no difference 
between the two groups in primary success (100% vs 99.6%, p=0.16) and in 30-days major complications: death (0% vs 0.8%, p=0.6), 
major stroke (0% vs 0.7%, p=0.42), and minor stroke (0% vs 1.1%, p=0.36).
Conclusion:  In our experience, in symptomatic patients with high-risk lesions, the use of double EPDs (proximal and distal) is safe and 
effective in minimizing the risk of cerebral embolization
